Monday’s Morning Meeting prompted by the CNBC Investing Club with Jim Cramer highlighted the positive performance of the market in September, historically the worst month of the year. Despite this reputation, the Dow, S&P 500, and Nasdaq were all set for monthly gains, with some reaching record-high closes. Jim Cramer emphasized that the bull market continues to defy seasonal tendencies, and the third quarter has been great for stocks overall.
The S&P Short Range Oscillator was noted to be overbought, potentially coming to an end if there was a lower close on Monday. Jim Cramer mentioned previous sales of Meta Platforms and Alphabet due to their recent gains, demonstrating a disciplined approach to trading during the market’s fluctuations. The stream also touched on Abbott Laboratories heading to trial in St. Louis over allegations regarding specialized baby formula, with Cramer predicting that the company may face another loss in court. Despite this, he highlighted Abbott as a great stock to be invested in, advising investors to wait for a trial loss and then buy on the dip.
During a rapid-fire segment at the end of the video, stocks such as JPMorgan, CVS Health, Ford, General Motors, PayPal, and Alibaba were discussed. Jim Cramer’s Charitable Trust is currently long on META, GOOGL, and ABT. Subscribers to the CNBC Investing Club with Jim Cramer receive trade alerts before Jim makes a trade, with certain waiting periods observed before executing those trades. While the information provided by the Investing Club is subject to terms and conditions, privacy policy, and disclaimer, no specific outcome or profit is guaranteed, and no fiduciary obligation or duty is created by receiving information from the Investing Club.
Overall, the Morning Meeting highlighted the strength of the market in defying historical trends and continuing its upward trajectory. With the Dow, S&P 500, and Nasdaq all showing gains for the month, the third quarter has proven to be successful for stocks. The discussion on the S&P Short Range Oscillator being overbought and potential sales of certain stocks demonstrated a disciplined approach to trading during market fluctuations. Abbott Laboratories’ upcoming trial in St. Louis was also mentioned, with Jim Cramer predicting a potential loss for the company but still affirming its value as a great stock to invest in.
The rapid-fire segment covered various stocks, including JPMorgan, CVS Health, Ford, General Motors, PayPal, and Alibaba, providing insights into potential investment opportunities. Jim Cramer’s approach to trading, which includes trade alerts for subscribers and waiting periods before executing trades, adds a layer of transparency and caution to the investment process. The Investing Club’s terms and conditions, privacy policy, and disclaimer provide the necessary disclaimers and information for members, emphasizing that no specific outcome or profit is guaranteed, and no fiduciary obligation exists as a result of receiving information from the Investing Club.
